Drug profile · INN
alogliptin and metformin hydrochloride
ALOGLIPTIN AND METFORMIN HYDROCHLORIDE
alogliptin and metformin hydrochloride (ALOGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — alogliptin and metformin hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 4
- Data quality
- 0.84
Quick answer
alogliptin and metformin hydrochloride (ALOGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is alogliptin and metformin hydrochloride?
alogliptin and metformin hydrochloride (ALOGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for alogliptin and metformin hydrochloride?
ALOGLIPTIN AND METFORMIN HYDROCHLORIDE is a marketed brand name for alogliptin and metformin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of alogliptin and metformin hydrochloride?
alogliptin and metformin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.